Happy Lunar New Year 2017: the Rooster has already produced some good clinical and pharmacology pulmonary papers

Happy Lunar New Year 2017: the Rooster has already produced some good clinical and pharmacology pulmonary papers

January 28, 2017

There is a good crop of clinical papers in the latest issue of the journal Pulmonary Pharmacology and Therapeutics, have a look:

A systematic review with meta-analysis of fluticasone furoate/vilanterol combination for the treatment of stable COPD
https://www.sciencedirect.com/science/article/pii/S1094553916300736?dgci...

Fast onset of action of glycopyrronium compared with tiotropium in patients with moderate to severe COPD — A randomised, multicentre, crossover trial
https://www.sciencedirect.com/science/article/pii/S1094553916301845?dgci...

Pharmacokinetics of tiotropium administered by Respimat® in asthma patients: Analysis of pooled data from Phase II and III clinical trials
https://www.sciencedirect.com/science/article/pii/S1094553916301274?dgci...

Acute cardiovascular safety of two formulations of beclometasone dipropionate/formoterol fumarate in COPD patients: A single-dose, randomised, placebo-controlled crossover study
https://www.sciencedirect.com/science/article/pii/S1094553916301511?dgci...

The papers will come handy when planning the development of future molecules and of course generics.

Happy New Year 2017!
Philippe

About Aedestra (www.aedestra.com): Aedestra is an inhaled product development company. We develop inhaled dosage form: DPI, pMDI, Nasal, Nebule and SoftMist: Generics in particular. Aedestra can help you develop the right product in the right way by providing strategic and technical expertise. Get in touch now to expand and develop your inhaled portfolio: www.aedestra.com.